Seizures Clinical Trials

Find Seizures Clinical Trials Near You

Overnight Temporal Interference Stimulation of Bilateral Hippocampi to Reduce Epileptogenic Biomarkers and Improve Sleep in Temporal Lobe Epilepsy

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to gauge whether overnight, non-invasive temporal interference (TI) stimulation aimed at the hippocampus can reduce abnormal brain activity linked to seizures and improve sleep in adults with drug-resistant temporal lobe epilepsy. The main questions are: Does overnight TI stimulation lower seizure-related EEG activity during sleep? Does overnight TI stimulation improve sleep quality and sleep patterns measured overnight in the lab? Researchers will compare each participant's nights without stimulation to nights with active stimulation, and will also look at a night after stimulation ends to see whether any changes last. Participants will: Stay in-lab for six days for overnight sleep and EEG monitoring Have one night of monitoring without stimulation Receive TI stimulation during sleep for several nights Have another night of monitoring without stimulation after the stimulation nights Complete brief questionnaires and thinking/memory tasks before and after the stimulation nights Be checked for side effects and comfort during the study and at follow-up

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Age 18 - 70 years

• Diagnosis of focal drug-resistant temporal lobe epilepsy

• Candidate for in-laboratory overnight monitoring with PSG and scalp EEG, with ability to comply with study procedures

• Stable antiseizure medication regimen for at least 1 week prior to admission

• Capacity to provide consent

Locations
United States
North Carolina
Anphy Lab - Inside Hock Plaza
RECRUITING
Durham
Contact Information
Primary
Birgit Frauscher, MD, PhD
birgit.frauscher@duke.edu
919-613-9386
Backup
Bruna Kfoury, Pharm.D.
bk282@duke.edu
470-312-7573
Time Frame
Start Date: 2026-10-15
Estimated Completion Date: 2026-10-30
Participants
Target number of participants: 20
Treatments
Experimental: Single Group: Overnight TI Stimulation and Within-Subject No-Stimulation Control Nights
Single-group, within-subject protocol with in-laboratory overnight PSG and scalp EEG. Participants complete one baseline night with no stimulation, followed by three consecutive nights of active overnight temporal interference (TI) stimulation targeting bilateral hippocampi, then one post-treatment night with no stimulation to assess persistence. Evening and morning EEG biomarker recordings are collected throughout, with safety/tolerability monitoring and pre/post cognitive and mood assessments.
Related Therapeutic Areas
Sponsors
Leads: Duke University
Collaborators: St. Anne's University Hospital Brno, Czech Republic

This content was sourced from clinicaltrials.gov